Article Text
Abstract
Objective: To describe a large pedigree with Charcot–Marie–Tooth disease type 1A (CMT1A) duplication in which severe pelvic and thigh musculature weakness occurred in two patients, detected by analysing the leg muscle atrophy pattern on magnetic resonance imaging (MRI).
Methods: The pedigree comprised 18 patients, aged between 15 and 85 (median 46) years, who were serially evaluated for up to three decades. All 18 patients and 13 non-affected at-risk people underwent electrophysiological examination. An MRI study of lower limb musculature was carried out in four patients. Three patients underwent sural-nerve biopsy. Genetic testing was carried out in 17 patients and in all 13 at-risk normal people.
Results: Fourteen patients were asymptomatic or slightly disabled. The two oldest patients, aged 84 and 80, showed a moderate phenotype. Two other patients, aged 70 and 53, showed late-onset and gradually progressive peroneal paresis extending up to the thigh and pelvic musculature, resulting in waddling gait. MRI scans of all three patients with a mild phenotype showed subtle and subclinical fatty infiltration of calf anterolateral muscle compartments, with thigh muscle involvement in one patient, and extensive atrophy of intrinsic foot muscles. In the youngest patient with proximal leg weakness, the MRI scan showed massive fatty atrophy of all the calf muscles, posteromedial thigh muscle compartments, and internal and external hip rotator muscles. Sural-nerve biopsy specimens showed hypertrophic neuropathy with no superimposed inflammation. Good correlation was seen between electrophysiological and genetic testing.
Conclusions: Late in the clinical course, a small proportion of patients with CMT1A develop severe proximal leg weakness, and long-term follow-up is essential for its detection. MRI scans may show subclinical involvement of the thigh musculature.
- CIDP, chronic inflammatory demyelinating polyneuropathy
- CMAP, compound muscle action potential
- CMT1A, Charcot–Marie–Tooth disease type 1A
- CMTNS, CMT Neuropathy Score
- DML, distal motor latency
- EMG, electromyogram
- FDS, Functional Disability Scale
- MCV, motor conduction velocity
- MRC, Medical Research Council
- MRI, magnetic resonance imaging
- MUP, motor unit potential
- SCV, sensory conduction velocity
- SNAP, sensory nerve action potential
- TLI, terminal latency index
- TR/TE, repetition time/echo time
Statistics from Altmetric.com
- CIDP, chronic inflammatory demyelinating polyneuropathy
- CMAP, compound muscle action potential
- CMT1A, Charcot–Marie–Tooth disease type 1A
- CMTNS, CMT Neuropathy Score
- DML, distal motor latency
- EMG, electromyogram
- FDS, Functional Disability Scale
- MCV, motor conduction velocity
- MRC, Medical Research Council
- MRI, magnetic resonance imaging
- MUP, motor unit potential
- SCV, sensory conduction velocity
- SNAP, sensory nerve action potential
- TLI, terminal latency index
- TR/TE, repetition time/echo time
Footnotes
-
Published Online First 20 June 2006
-
This study was supported by the Centro de Investigación de Enfermedades Neurólogicas (CIEN), Nodo CO3/CO6, (ISCIII, Madrid, Spain), Instituto de Formación e Investigación Marqués de Valdecilla (IFIMAV, Santander, Spain) and FIS grant number PI050879.
-
Competing interests: None.
-
Patient consent was obtained to publish the figures in this paper.